High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care

We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19. We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1.8%). We conclude DKA is common and severe in individuals hospitalise...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Nina, Fink, Douglas, Cai, James, Lee, Yun-Ni, Davies, Zoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323680/
https://www.ncbi.nlm.nih.gov/pubmed/32615280
http://dx.doi.org/10.1016/j.diabres.2020.108291
_version_ 1783551815313260544
author Goldman, Nina
Fink, Douglas
Cai, James
Lee, Yun-Ni
Davies, Zoe
author_facet Goldman, Nina
Fink, Douglas
Cai, James
Lee, Yun-Ni
Davies, Zoe
author_sort Goldman, Nina
collection PubMed
description We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19. We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1.8%). We conclude DKA is common and severe in individuals hospitalised with COVID-19.
format Online
Article
Text
id pubmed-7323680
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73236802020-06-30 High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care Goldman, Nina Fink, Douglas Cai, James Lee, Yun-Ni Davies, Zoe Diabetes Res Clin Pract Article We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19. We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1.8%). We conclude DKA is common and severe in individuals hospitalised with COVID-19. Elsevier B.V. 2020-08 2020-06-29 /pmc/articles/PMC7323680/ /pubmed/32615280 http://dx.doi.org/10.1016/j.diabres.2020.108291 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Goldman, Nina
Fink, Douglas
Cai, James
Lee, Yun-Ni
Davies, Zoe
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title_full High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title_fullStr High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title_full_unstemmed High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title_short High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
title_sort high prevalence of covid-19-associated diabetic ketoacidosis in uk secondary care
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323680/
https://www.ncbi.nlm.nih.gov/pubmed/32615280
http://dx.doi.org/10.1016/j.diabres.2020.108291
work_keys_str_mv AT goldmannina highprevalenceofcovid19associateddiabeticketoacidosisinuksecondarycare
AT finkdouglas highprevalenceofcovid19associateddiabeticketoacidosisinuksecondarycare
AT caijames highprevalenceofcovid19associateddiabeticketoacidosisinuksecondarycare
AT leeyunni highprevalenceofcovid19associateddiabeticketoacidosisinuksecondarycare
AT davieszoe highprevalenceofcovid19associateddiabeticketoacidosisinuksecondarycare

Ejemplares similares